Because CD4+ T cells are central in initiating and perpetuating the chronic autoimmune response in rheumatic diseases, many biologicals are aimed at interfering with T-cell activation and/or migration.A major advance in our understanding of T-cell activation has been the identification of the critical co-stimulatory molecules on T cells, such as CD28, lymphocyte function-associated antigen (LFA)-1